Supriya Lifescience Limited has informed that the European Directorate for the Quality of Medicines (EDQM) has granted Attestation of Inspection (EU-GMP) for Lote API Facility, Ratnagiri, Maharashtra.
It ensures sufficient serum estradiol levels to alleviate menopausal symptoms
Lumpi-ProVacind is used for the prophylactic immunization of animals against Lumpy Skin Disease, which illicit protection for about one year
Triazolam tablets are used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep)
Upon approval, XPHOZAH would be the first and only phosphate absorption inhibitor, offering patients a novel mechanism
Tafasitamab is conditionally approved by both the U.S. Food and Drug Administration and European Medicines Agency
If approved, the vaccine could help simplify the meningococcal vaccination schedule and provide the broadest serogroup coverage of any meningococcal vaccine
All claims against the company in the litigation have now been dismissed.
The current approval is first of the many fillings made by the company's CDMO partners from the flagship facility in Bangalore
The cash and debt free consideration value is €370 million.
Subscribe To Our Newsletter & Stay Updated
